GondolaBio

Develops clinical-stage therapeutics for rare genetic diseases.

BiotechnologyPharmaceuticals gondolabio.com ↗

Company facts

Founded
2024
Employees
45
Headquarters
United States
Type
Private
Funding
Corporate Round · $300M · 2024
Subsidiaries
Portal Therapeutics